Warning: The NCBI web site requires JavaScript to function. more...
High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease.
Pisetsky DS, Erlandsson-Harris H, Andersson U.
Arthritis Res Ther. 2008;10(3):209. Epub 2008 Jun 30. Review.
Related citations
Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
van Beijnum JR, Buurman WA, Griffioen AW.
Angiogenesis. 2008;11(1):91-9. Epub 2008 Feb 9. Review.
Mechanisms of Disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis.
Jiang W, Pisetsky DS.
Nat Clin Pract Rheumatol. 2007 Jan;3(1):52-8. Review.
HMGB1: endogenous danger signaling.
Klune JR, Dhupar R, Cardinal J, Billiar TR, Tsung A.
Mol Med. 2008 Jul-Aug;14(7-8):476-84. Review.
High mobility group box 1 protein interacts with multiple Toll-like receptors.
Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E.
Am J Physiol Cell Physiol. 2006 Mar;290(3):C917-24. Epub 2005 Nov 2.
Is HMGB1 an osteocyte alarmin?
Bidwell JP, Yang J, Robling AG.
J Cell Biochem. 2008 Apr 15;103(6):1671-80. Review.
The translocation of HMGB1 during cell activation and cell death.
Gauley J, Pisetsky DS.
Autoimmunity. 2009 May;42(4):299-301. Review.
Inhibition of tumor angiogenesis by HMGB1 A box peptide.
Zhang CL, Shu MG, Qi HW, Li LW.
Med Hypotheses. 2008;70(2):343-5. Epub 2007 Jul 13.
High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus.
Urbonaviciute V, Voll RE.
J Intern Med. 2011 Oct;270(4):309-18. doi: 10.1111/j.1365-2796.2011.02432.x.
High mobility group box 1 in the pathogenesis of inflammatory and autoimmune diseases.
Voll RE, Urbonaviciute V, Herrmann M, Kalden JR.
Isr Med Assoc J. 2008 Jan;10(1):26-8. Review.
[Role of HMGB1 in rheumatic diseases].
Zhou JG, Zheng M.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2007 Jul;36(4):412-6. Review. Chinese.
HMGB1 as a DNA-binding cytokine.
Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ.
J Leukoc Biol. 2002 Dec;72(6):1084-91. Review.
Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products.
Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP, Arnold B, Bianchi ME, Manfredi AA, Rovere-Querini P.
J Immunol. 2005 Jun 15;174(12):7506-15.
HMGB1 in systemic lupus Erythematosus: Its role in cutaneous lesions development.
Abdulahad DA, Westra J, Limburg PC, Kallenberg CG, Bijl M.
Autoimmun Rev. 2010 Aug;9(10):661-5. Epub 2010 May 21. Review.
The role of HMGB1 in the pathogenesis of rheumatic disease.
Andersson U, Harris HE.
Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):141-8. Review.
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.
Urbonaviciute V, Fürnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, Kalden JR, Schett G, Rovere-Querini P, Herrmann M, Voll RE.
J Exp Med. 2008 Dec 22;205(13):3007-18. Epub 2008 Dec 8.
High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin.
Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ.
J Leukoc Biol. 2007 Jan;81(1):59-66. Epub 2006 Sep 11.
The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
Hreggvidsdottir HS, Ostberg T, Wähämaa H, Schierbeck H, Aveberger AC, Klevenvall L, Palmblad K, Ottosson L, Andersson U, Harris HE.
J Leukoc Biol. 2009 Sep;86(3):655-62. Epub 2009 Jun 29.
High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.
Bianchi ME, Manfredi AA.
Immunol Rev. 2007 Dec;220:35-46. Review.
Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.
DeMarco RA, Fink MP, Lotze MT.
Mol Immunol. 2005 Feb;42(4):433-44.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on